Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17361
Country/Region: Cameroon
Year: 2016
Main Partner: Cameroon Baptist Convention Health Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $14,025,004 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Pediatric Care and Support (PDCS) $1,103,032
Testing: HIV Testing and Counseling (HVCT) $1,637,652
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,546,630
Treatment: Adult Treatment (HTXS) $7,478,343
Treatment: Pediatric Treatment (PDTX) $2,259,347
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 42,752
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 33,912
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 34,107
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 25,421
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 163,629
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 136,596
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 97,322
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 77,888
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 337,810
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 273,817
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,223
HTS_TST Service Delivery Point (Facility): Index testing 2017 668
HTS_TST Service Delivery Point (Facility): Inpatient 2017 25,244
HTS_TST Service Delivery Point (Facility): Inpatient 2017 23,882
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,800
HTS_TST Service Delivery Point (Facility): Other PITC 2017 2,342
HTS_TST Service Delivery Point (Facility): Outpatient 2017 169,658
HTS_TST Service Delivery Point (Facility): Outpatient 2017 120,753
HTS_TST Service Delivery Point (Facility): Pediatric 2017 4,488
HTS_TST Service Delivery Point (Facility): Pediatric 2017 7,708
HTS_TST Service Delivery Point (Facility): PMTCT 2017 76,866
HTS_TST Service Delivery Point (Facility): PMTCT 2017 125,667
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 6,747
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 6,238
HTS_TST Service Delivery Point (Facility): VCT 2017 37,910
HTS_TST Service Delivery Point (Facility): VCT 2017 284
HTS_TST Service Delivery Point (Facility): VMMC 2017 148
HTS_TST Sum of Aggregated Age/Sex <15 2017 76,859
HTS_TST Sum of Aggregated Age/Sex <15 2017 59,333
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 260,951
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 214,484
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 337,810
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 273,817
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1,821
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1,903
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,259
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,232
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 12,486
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 12,815
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 9,782
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 9,202
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,388
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,538
PMTCT_ART New on ART 2017 5,201
PMTCT_ART New on ART 2017 2,563
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 134,325
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 73,449
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 4,141
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2,822
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 3,343
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 1,384
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 269
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 50
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 207
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 82
PMTCT_EID Sum of Infant Age disaggregates 2017 7,484
PMTCT_EID Sum of Infant Age disaggregates 2017 4,206
PMTCT_STAT By: Known positives at entry 2017 2,561
PMTCT_STAT By: Known positives at entry 2017 1,576
PMTCT_STAT By: Number of new positives identified 2017 5,328
PMTCT_STAT By: Number of new positives identified 2017 2,851
PMTCT_STAT Number of new ANC and L&D clients 2017 140,852
PMTCT_STAT Number of new ANC and L&D clients 2017 76,833
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 134,325
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 73,449
PMTCT_STAT Sum of Positives Status disaggregates 2017 7,889
PMTCT_STAT Sum of Positives Status disaggregates 2017 4,427
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 111
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 313
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 837
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2,053
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 72
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 172
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 418
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 984
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,540
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 3,783
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,438
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 3,524
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 8,282
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 9,248
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 8,656
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 7,542
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 263
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 520
TB_SCREENDX Screen Result: Screened Positive for TB 2017 9,906
TB_SCREENDX Screen Results: Screened Positive for TB 2017 11,197
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 2,298
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 1,409
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 16,172
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 17,085
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,856
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,193
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,340
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,288
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 27,734
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 27,906
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 152
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 628
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,137
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,903
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 97
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 324
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 585
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,840
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,971
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 6,695
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,195
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 7,441
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,599
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,576
TX_CURR Aggregated Age/Sex: <15 Male 2017 828
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,413
TX_CURR Aggregated Age/Sex: 15+ Female 2017 31,996
TX_CURR Aggregated Age/Sex: 15+ Female 2017 34,804
TX_CURR Aggregated Age/Sex: 15+ Male 2017 15,934
TX_CURR Aggregated Age/Sex: 15+ Male 2017 16,412
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 50,318
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 55,203
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,427
TX_CURR Sum of Aggregated Age/Sex <15 2017 3,989
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 47,930
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 51,216
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 50,357
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 55,205
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 639
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1,070
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 294
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 690
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 16,205
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 19,092
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 8,160
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 9,064
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 25,723
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 29,916
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 25,298
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 29,916
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,032
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 31,312
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 4,530
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 28,182
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 254
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,620
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 151
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,043
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,832
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 18,234
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,293
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 7,285
TX_PVLS Numerator: Indication: Routine 2017 4,196
TX_PVLS Numerator: Indication: Routine 2017 28,182
TX_PVLS Numerator: Indication: Targeted 2017 334
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 259
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,802
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 149
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,160
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,271
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 19,190
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,353
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 9,206
TX_PVLS_den Denominator: Indication: Routine 2017 4,660
TX_PVLS_den Denominator: Indication: Routine 2017 31,312
TX_PVLS_den Denominator: Indication: Targeted 2017 371
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 942
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,288
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 526
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 814
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10,462
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13,815
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,692
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7,095
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 16,622
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 23,012
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 25,723
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 29,913
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,496
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,634
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 868
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,017
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16,057
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17,282
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,301
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,755
Cross Cutting Budget Categories and Known Amounts Total: $500,000
Human Resources for Health $500,000